Curtiland Deville, MD, is the Associate Proton Director at the Johns Hopkins Proton Therapy Center, Clinical Director of Radiation Oncology at Sibley Memorial Hospital, and an Associate Professor at the Johns Hopkins University School of Medicine.
Dr. Deville is an expert in proton therapy and a leader in several institutional and national clinical trials. He treats genitourinary malignancies, including prostate cancer, and soft tissue sarcomas, and is dedicated to creating individualized treatment plans for each patient.
Dr. Deville's research interests involve better targeting tumors through proton and photon therapies and reducing radiation to healthy tissues. He analyzes toxicity rates with modern radiation techniques and uses the most advanced technology for his patients’ care.
Dr. Deville is a Senior Editor for Advances in Radiation Oncology, as well as a reviewer for several journals that focus on radiation oncology.
Dr. Deville has an interest in physician workforce diversity. He is the immediate past Chair of the American Society of Radiation Oncology's Committee on Health Equity, Diversity and Inclusion and Chair of the American Society of Clinical Oncology’s Diversity in Oncology Subcommittee.